Form 4 for MOVE Corvex, Inc.
Accepted 2026-01-28 00:00:00 ET · period of report 2026-01-26 · accession 0001193125-26-027443 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-28 | 2026-01-27 | MOVE | Cogan Jeremy | CFO | S - Sale+OE | $20.78 | -28.7K | 81.3K | -26% | -$597.3K |
| D | 2026-01-28 | 2026-01-26 | MOVE | Cogan Jeremy | CFO | M - OptEx | $1.25 | +64.8K | 89.2K | +266% | +$81.0K |
| D | 2026-01-28 | 2026-01-26 | MOVE | Cogan Jeremy | CFO | M - OptEx | $0.00 | -64.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-27 | S | D | 13,179 | $20.63 | 68,151 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.51 to $21.50 inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 2 | Common | Common Stock | 2026-01-27 | S | D | 5,548 | $21.76 | 62,603 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.70 to $22.24 inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 3 | Common | Common Stock | 2026-01-27 | S | D | 2,099 | $23.37 | 60,504 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.335 to $23.38 inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 4 | Common | Common Stock | 2026-01-26 | M | A | 64,834 | $1.25 | 89,240 | D | — | — | |
| 5 | Common | Common Stock | 2026-01-27 | S | D | 3,288 | $19.11 | 85,952 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.40 to $19.35, inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 6 | Common | Common Stock | 2026-01-27 | S | D | 4,622 | $20.07 | 81,330 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.50 to $20.50, inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 7 | Derivative | Stock Options (Right to Buy) | 2026-01-26 | M | D | 64,834 | $0.00 | 0 | D | $1.25 · — to 2026-03-15 | 64,834 Common Stock | (F7) This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025. |